Abbott Laboratories $ABT Reported Q2 EPS of $0.82 which beat the $0.80 estimate. Revenue came in at $7.98 billion which missed the $8 billion consensus estimate. The company also said it sees an FY19 adjusted EPS of $3.21-$3.27 versus the $3.22 estimate. The stock was up more than 1% Wednesday morning.